Cargando…
Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment
BACKGROUND: The process used to prefer certain products across drug classes for diabetes is generally focused on comparative effectiveness and cost. However, payers rarely tie patient preference for treatment attributes to formulary management resulting in a misalignment of value defined by provider...
Autores principales: | Panchal, Rupesh, Nguyen, Danielle, Ghule, Priyanka, Li, Niying, Giannouchos, Theodoros, Pan, Raymond J, Biskupiak, Joseph, Britton, Laura, Nohavec, Robert, Slager, Stacey, Ngorsuraches, Surachat, Brixner, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387929/ https://www.ncbi.nlm.nih.gov/pubmed/36705280 http://dx.doi.org/10.18553/jmcp.2023.29.2.139 |
Ejemplares similares
-
Benefit–risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment
por: Wanishayakorn, Tanatape, et al.
Publicado: (2016) -
Using a discrete choice experiment to elicit patients’ preferences and willingness-to-pay for knee osteoarthritis treatments in Thailand
por: Luksameesate, Parnnaphat, et al.
Publicado: (2023) -
Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system
por: Giannouchos, Theodoros V., et al.
Publicado: (2021) -
A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
por: Nimdet, Khachapon, et al.
Publicado: (2015) -
Using latent class and quantum models to value equity in health care: a tale of 2 stories
por: Ngorsuraches, Surachat
Publicado: (2021)